These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2574693)

  • 1. Vagotomy for duodenal ulcer resistant to H2-receptor antagonists.
    Vassilakis JS; Xynos E; Mantidis A; Zoras OJ; Nikolopoulos N
    Digestion; 1989; 44(1):1-6. PubMed ID: 2574693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy?
    Primrose JN; Naik KS; Blackett RL; King RF; Holmfield JH; Lagopolous M; Johnston D
    Gut; 1990 Jul; 31(7):763-6. PubMed ID: 1973394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists.
    Primrose JN; Axon AT; Johnston D
    Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1031-5. PubMed ID: 3130125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of childhood duodenal ulcers.
    Chan KL; Tam PK; Saing H
    J Pediatr Surg; 1997 Nov; 32(11):1609-11. PubMed ID: 9396537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective vagotomy and truncal vagotomy and pyloroplasty for duodenal ulcer: a clinical review.
    McLeod RS; Cohen Z
    Can J Surg; 1979 Mar; 22(2):113-20. PubMed ID: 376072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between gastric acid secretion and recurrent duodenal ulcer after selective vagotomy and pyloroplasty in men.
    Kronborg O; Madsen P
    Scand J Gastroenterol; 1976; 11(5):465-9. PubMed ID: 959759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic vagotomy and open pyloroplasty for bleeding duodenal ulcer not controlled endoscopically.
    Ng JW; Yeung GH
    Surg Laparosc Endosc; 1998 Apr; 8(2):127-31. PubMed ID: 9566567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenogastric reflux before and after surgical or medical therapy for duodenal ulcer.
    Avgerinos A; Stavropoulos GS; Yalouris A; Rekoumis G; Stavraka-Kakavaki A; Raptis S
    Am J Gastroenterol; 1990 Feb; 85(2):150-3. PubMed ID: 1967899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the pre-operative response to H2 receptor antagonists on the outcome of highly selective vagotomy for duodenal ulcer.
    Goodman AJ; Kerrigan DD; Johnson AG
    Br J Surg; 1987 Oct; 74(10):897-9. PubMed ID: 2889503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different strategies for treatment of duodenal ulcer.
    Sonnenberg A
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1185-7. PubMed ID: 2859078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of surgery in the treatment of duodenal ulcer].
    Picaud R; Caamano A
    J Chir (Paris); 1988 Apr; 125(4):283-8. PubMed ID: 2899084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior vagotomy and anterior seromyotomy as elective surgery for duodenal ulcer disease.
    Mouiel J; Kathouda N
    Hepatogastroenterology; 1999; 46(27):1507-16. PubMed ID: 10430285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective vagotomy or truncal vagotomy and pyloroplasty for duodenal ulcer.
    Perez-Avila C; Duthie HL
    Proc R Soc Med; 1974 Sep; 67(9):838-40. PubMed ID: 4431788
    [No Abstract]   [Full Text] [Related]  

  • 14. Truncal vagotomy with "antrectomy" or pyloroplasty for duodenal ulcer. A five-year follow-up study.
    Berger T; Kock NG; Norberg PB
    Acta Chir Scand; 1972; 138(5):499-504. PubMed ID: 5055982
    [No Abstract]   [Full Text] [Related]  

  • 15. Faecal fat excretion after truncal, selective, and highly selective vagotomy for duodenal ulcer.
    Edwards JP; Lyndon PJ; Smith RB; Johnston D
    Gut; 1974 Jul; 15(7):521-5. PubMed ID: 4430470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of H2-receptor antagonists on the outcome of treatment of perforated duodenal ulcer.
    Macintyre IM; Millar A
    J R Coll Surg Edinb; 1990 Dec; 35(6):348-52. PubMed ID: 1982317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative evaluation of the efficacy of pylorus-destroying and pylorus-preserving operations with vagotomy in bleeding duodenal ulcers].
    Shepet'ko GN
    Lik Sprava; 1997; (5):131-2. PubMed ID: 9491720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
    Pan S; Liao CH
    Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: A controlled comparison of highly selective vagotomy against truncal vagotomy and pyloroplasty for duodenal ulcer.
    Koffman CG; Perez-Avila C; Irvin RR; Duthie HL
    Gut; 1975 Oct; 16(10):829. PubMed ID: 1107173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.